Abstract
HIV infected patients treated with highly active antiretroviral therapy (HAART) may be at increased risk of cardiovascular events, particularly if based upon the use of protease inhibitors (PI). We investigated the haemostatic markers of cardiovascular risk in 115 HIV infected subjects, divided into four groups: 1) patients naive to antiretroviral therapy (Naive; n=34 patients), or subjects that had been on a stable combination therapy for ≥12 months with either: 2) double reverse transcriptase nucleoside analogue inhibitors therapy (2NRTI; n=26), 3) 2NRTI backbone plus a non-nucleoside analogue reverse transcriptase inhibitor (NNRTI; n=27), and 4) on a PI based regimen (PI; n=28). Forty-four healthy subjects were included as controls. Naive as well as 2NRTI and NNRTI differed from controls for higher F1+2 (P < .0001) and FVII (P < .007) levels. When comparing PI patients with controls we observed significantly higher levels of Fbg (P=.035), FVII (P < .0001), TM (P < .0089), vWF (P=.009), and F1+2 (P < .0001). The only difference observed among the 4 groups of HIV infected patients was a significantly lower level of F1+2 in PI as compared with NNRTI patients (P=.05) At least one abnormal result was observed in ≥ 90.6% of HIV infects groups, vs 43.2% of controls (P < .0001 in all cases). In conclusion, a) HIV infection per se may alter the haemostatic markers of cardiovascular risk, b) minor differences were observed among the different classes of HIV infected patients, namely between NNRTI and PI treated patients.
Keywords: HIV, haemostatic marker, cardiovascular risk, antiretroviral therapy
Current HIV Research
Title: Haemostatic Activation in HIV Infected Patients Treated with Different Antiretroviral Regimens
Volume: 6 Issue: 1
Author(s): Angelo Pan, Sophie Testa, Eugenia Quiros Roldan, Carmine Tinelli, Umberto Bodini, Barbara Cadeo, Giuseppe Carnevale, Ida Martinelli, Renato Maserati, Pietro Morstabilini, Elena Seminari, Liana Signorini and Giampiero Carosi
Affiliation:
Keywords: HIV, haemostatic marker, cardiovascular risk, antiretroviral therapy
Abstract: HIV infected patients treated with highly active antiretroviral therapy (HAART) may be at increased risk of cardiovascular events, particularly if based upon the use of protease inhibitors (PI). We investigated the haemostatic markers of cardiovascular risk in 115 HIV infected subjects, divided into four groups: 1) patients naive to antiretroviral therapy (Naive; n=34 patients), or subjects that had been on a stable combination therapy for ≥12 months with either: 2) double reverse transcriptase nucleoside analogue inhibitors therapy (2NRTI; n=26), 3) 2NRTI backbone plus a non-nucleoside analogue reverse transcriptase inhibitor (NNRTI; n=27), and 4) on a PI based regimen (PI; n=28). Forty-four healthy subjects were included as controls. Naive as well as 2NRTI and NNRTI differed from controls for higher F1+2 (P < .0001) and FVII (P < .007) levels. When comparing PI patients with controls we observed significantly higher levels of Fbg (P=.035), FVII (P < .0001), TM (P < .0089), vWF (P=.009), and F1+2 (P < .0001). The only difference observed among the 4 groups of HIV infected patients was a significantly lower level of F1+2 in PI as compared with NNRTI patients (P=.05) At least one abnormal result was observed in ≥ 90.6% of HIV infects groups, vs 43.2% of controls (P < .0001 in all cases). In conclusion, a) HIV infection per se may alter the haemostatic markers of cardiovascular risk, b) minor differences were observed among the different classes of HIV infected patients, namely between NNRTI and PI treated patients.
Export Options
About this article
Cite this article as:
Pan Angelo, Testa Sophie, Roldan Quiros Eugenia, Tinelli Carmine, Bodini Umberto, Cadeo Barbara, Carnevale Giuseppe, Martinelli Ida, Maserati Renato, Morstabilini Pietro, Seminari Elena, Signorini Liana and Carosi Giampiero, Haemostatic Activation in HIV Infected Patients Treated with Different Antiretroviral Regimens, Current HIV Research 2008; 6 (1) . https://dx.doi.org/10.2174/157016208783571928
DOI https://dx.doi.org/10.2174/157016208783571928 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Different Lifestyles in Young Women From Urban and Rural Areas May Explain Different Cardiovascular Risk
Vascular Disease Prevention (Discontinued) Metabolic Effects of Renal Denervation
Current Clinical Pharmacology Psoriasis vulgaris and Psoriasis pustulosa – Epidemiology, Quality of Life, Comorbidities and Treatment
Current Rheumatology Reviews The Role of Intravenous Dihydropyridine Calcium Channel Blockers in the Perioperative Management of Patients Undergoing Coronary Artery Bypass Surgery
Current Vascular Pharmacology Inflammatory Mechanisms of Injury and Recovery after Intracerebral Hemorrhage
Current Immunology Reviews (Discontinued) Current Insights into the Role of HIF-1 in Cutaneous Wound Healing
Current Molecular Medicine Current Evidence for Antithrombotic Therapy after Peripheral Vascular Interventions
Current Vascular Pharmacology Thoughtful Insights into the Therapeutic Armamentarium of Chalcones: 10 Years of Glorious Journey
Current Bioactive Compounds Early Life Programming of Obesity: The Impact of the Perinatal Environment on the Development of Obesity and Metabolic Dysfunction in the Offspring.
Current Diabetes Reviews Herbal Medicine as an Alternative Treatment in Autism Spectrum Disorder: A Systematic Review
Current Drug Metabolism The Emergence of Plasma Membrane Calcium Pump as a Novel Therapeutic Target for Heart Disease
Mini-Reviews in Medicinal Chemistry Good at Heart: Preserving Cardiac Metabolism during aging
Current Diabetes Reviews Variability in the Response to Non-pharmacological Treatments in Patients with Cardiovascular Diseases
Current Pharmacogenomics and Personalized Medicine Genetic and Environmental Influences on Therapeutic and Toxicity Outcomes: Studies with CYP2A6
Current Clinical Pharmacology Natural Compounds with Cell Growth Inhibitory Activity in Human Tumor Cell Lines
Anti-Cancer Agents in Medicinal Chemistry The Therapeutic Potential of Induced Pluripotent Stem Cells After Stroke: Evidence from Rodent Models
Current Stem Cell Research & Therapy Dietary Agents for Prostate Cancer Chemoprevention: An Overview
Current Cancer Therapy Reviews Fad Diets: Dietary Dilemmas, Predicaments, and Recommendations for its Use
Current Nutrition & Food Science Probiotics as an Alternative Strategy for Prevention and Treatment of Human Diseases: A Review
Inflammation & Allergy - Drug Targets (Discontinued) The Quality of Life of Thalassemic Patients: The Role of Endocrine Defect Compensation
Endocrine, Metabolic & Immune Disorders - Drug Targets